Medicare Part A and Part B Billing for the COVID-19 Vaccine and Monoclonal Antibody
Medicare Billing for COVID-19 Vaccine Shot Administration
How to Bill for COVID-19 Shot Administration
- You’ll be able to bill on single claims for the COVID-19 vaccine administration, or submit claims on a roster bill for multiple patients at one time.
- When COVID-19 vaccine doses are provided by the government without charge, only bill for the vaccine administration. Do not include the vaccine codes on the claim when the vaccines are free.
- If the Medicare beneficiary is enrolled in a Medicare Advantage Plan, submit your COVID-19 claims to original fee-for-service Medicare. This applies to all patients enrolled in Medicare Advantage in 2020 and 2021.
Helpful definitions
- Mass Immunizers: Mass immunizers can give flu, pneumococcal and COVID-19 shots, to groups of individuals (like people who live in a retirement community). Mass immunizers can be a traditional provider, like a physician, or a nontraditional provider, like a drug store, public health clinic or senior center. We created the mass immunizer specialty for those providers who wouldn't otherwise be eligible for Medicare enrollment. Mass immunizers must submit all claims as roster billed professional claims.
- Roster Billing: This is a way for you to submit multiple claims for flu, pneumococcal and COVID-19 shots. If you’re enrolled as a mass immunizer, you must use roster billing.
- You must administer the same type of shot to five or more people on the same date of service. You must bill each type of shot on a separate roster bill. You cannot combine flu, pneumococcal and COVID-19 vaccine codes on the same roster bill.
- It’s quick and easy to use roster billing for flu, pneumococcal and COVID-19 shots.
- Centralized Billers: Centralized billing allows mass immunizers to send all roster bill claims for flu, pneumococcal, and COVID-19 vaccinations to a single MAC, Novitas, for payment, regardless of where you administer them. Medicare makes geographic payment adjustments based on the locality where you administer the shot. You must submit all centralized biller claims as professional claims on a roster bill.
- Order: A communication from the treating physician/practitioner requesting a diagnostic test is performed for the patient.
How to Submit a Claim if You are a Medicare Advantage Plan Contracted Provider
Important information: If you are a Medicare Advantage contracted provider, submit claims for administering COVID-19 vaccines to original Medicare fee-for-service contractor, not the Medicare Advantage Plan.
National Government Services is the MAC for J6 - Illinois, Minnesota and Wisconsin, as well as JK - Connecticut, Maine, Massachusetts, New Hampshire, New York, Rhode Island and Vermont
How to Submit Part A Institutional Claims
If you use roster billing for institutional claims, you must administer shots to at least five patients on the same date, unless the institution is an inpatient hospital. You can also submit individual claims.
What are valid types of bills for Part A?
- 12X, Hospital Inpatient**
- 13X, Hospital Outpatient**
- 22X, SNF covered Part A stay (paid under Part B) and Inpatient Part B
- 23X, SNF Outpatient
- 34X, Home Health (Part B Only)
- 72X, Independent and Hospital-based Renal Dialysis Facility
- 75X, Comprehensive Outpatient Rehabilitation Facility
- 81X, Hospice (Non-hospital)
- 82X, Hospice (Hospital)
- 85X, Critical Access Hospital
**For hospitalized patients, Medicare pays for the COVID-19 shots separately from the DRG rate and disallows billing them on 11X.
How to Submit a Part A Institutional Claim
Submit and electronic claim or via DDE:
- Option 02, Claims Attachment
- Option 87, Roster Bill Entry
Paper Claims (must have an ASCA Waiver on file)
- CMS-1450 (UB-04)
- Roster form for patients (contact your MAC for this form)
How to Submit Part B Professional Claims
If you use roster billing for professional claims, you must administer the same type of shot to five or more people on the same date of service. You can also submit individual claims.
Electronic Claims Options available:
- Utilize your current claim submission software and Network Service Vendor.
- Submit claims using our provider portal NGSConnex.
- Use PC-ACE billing software to submit directly to your MAC. Download this free billing software from your MAC and electronically submit professional claim roster billing.
Paper Claims
- Health Insurance Claim Form (CMS-1500)
- Roster form for patients
How to Submit Institutional Claims
- For billing single (non-roster) claims for COVID-19 vaccines and monoclonal antibodies, follow the instructions in the article below.
- If you use roster billing for institutional claims, you must administer vaccinations to at least five patients on the same date, unless the institution is an inpatient hospital.
COVID-19 Vaccine or Monoclonal Antibody and Administration
Revenue Codes:
- 0771 – Preventive care services, vaccine administration
- 0636 – Pharmacy, requiring detailed coding
- Note: Do not bill the drug/revenue code 0636 when the drug is provided free of charge
- Note concerning Monoclonal antibody infusions:
- Medicare coverages all costs for monoclonal antibody infusion without any copayment due from the Medicare beneficiary; therefore, all costs for any saline (or other fluid) used for the infusion, as well as prophylactic use of Benadryl (or any other drug), is bundled into the administration fee and should not be separately billed on the claim
Condition Codes:
- 78 – New coverage not implemented by Medicare Advantage (Billed on claims for Medicare Advantage beneficiaries only)
Diagnosis Codes
- Monoclonal antibody infusion
-
- U071 as appropriate
Skilled Nursing Facility Inpatient
- When an institutional provider other than a SNF provider administers the COVID-19 vaccine or monoclonal antibody infusion to an inpatient of a SNF, the claim date of service must be the date of discharge or benefits exhaust date.
Rural Health Clinics and Federally Qualified Health Centers
- Independent and provider-based RHCs and FQHCs do not include charges for the COVID-19 vaccine and monoclonal antibodies on a claim form.
- Administration of these vaccines does not qualify as a visit when the only service provided is the administration of the COVID-19 vaccine and/or monoclonal antibodies.
- Even if there was were another reason for the visit, the RHCs do not report the charges for the vaccine on the 71X claim. However, FQHCs must report these services with their charges on the 77X claim for informational and data collection purposes only.
- Payment is made at the time of cost report settlement.
Roster Billing
Streamlined process for submitting vaccination claims for large groups of individuals.
- All patients have the same service
- Not used for single patient billing
The patient roster form includes the following with a single modified CMS-1500 claim form as roster cover document for each facility where the services are rendered:
- Patients name, address, Medicare number, date of birth and gender
- Date of service
- Beneficiary signature or stamped “Signature on File”
- Providers name and identification number
- Control number for contractor
How to Submit a Centralized Bill
Centralized Billers: Centralized billing allows mass immunizers to send all roster bill claims for flu, pneumococcal, and COVID-19 vaccinations to a single MAC, Novitas, for payment, regardless of where you administer the shots. Medicare makes geographic payment adjustments based on the locality where you administer the shot. You must submit all centralized biller claims as professional claims on a roster bill. You must operate in at least three MAC Jurisdictions.
Medicare Part B Payment for COVID-19 Vaccines and Certain Monoclonal Antibodies during the Public Health Emergency
CMS has released a set of toolkits for providers, states and insurers to help the health care system prepare and assist in swiftly administering these products once they become available. These resources are designed to increase the number of providers that can administer the products and ensure adequate reimbursement for administration in Medicare, while making it clear to private insurers and Medicaid programs their responsibility to cover these products at no charge to beneficiaries. This webpage provides the payment allowances and other related information for these products. For more information, review the COVID-19 provider toolkit.
Payment Allowances and Effective Dates for COVID-19 Vaccines and their Administration During the Public Health Emergency
Code | CPT Short Descriptor | Labeler Name | Vaccine/Procedure Name | Payment Allowance | Effective Dates |
---|---|---|---|---|---|
91300 | SARSCOV2 VAC 30MCG/0.3ML IM | Pfizer | Pfizer-Biontech Covid-19 Vaccine | $0.010* | 12/11/2020 – TBD |
0001A | ADM SARSCOV2 30MCG/0.3ML 1ST | Pfizer | Pfizer-Biontech Covid-19 Vaccine Administration – First Dose | $16.940** | 12/11/2020 – TBD |
0002A | ADM SARSCOV2 30MCG/0.3ML 2ND | Pfizer | Pfizer-Biontech Covid-19 Vaccine Administration – Second Dose | $28.390** | 12/11/2020 – TBD |
91301 | SARSCOV2 VAC 100MCG/0.5ML IM | Moderna | Moderna Covid-19 Vaccine | $0.010* | 12/18/2020 – TBD |
0011A | ADM SARSCOV2 100MCG/0.5ML1ST | Moderna | Moderna Covid-19 Vaccine Administration – First Dose | $16.940** | 12/18/2020 – TBD |
0012A | ADM SARSCOV2 100MCG/0.5ML2ND | Moderna | Moderna Covid-19 Vaccine Administration – Second Dose | $28.390** | 12/18/2020 – TBD |
91302 | SARSCOV2 VAC 5X10^10VP.5MLIM | AstraZeneca | AstraZeneca Covid-19 Vaccine | $0.010* | xx/xx/xxxx – TBD |
0021A | ADM SARSCOV2 5X10^10VP.5ML 1 | AstraZeneca | AstraZeneca Covid-19 Vaccine Administration – First Dose | $16.940** | xx/xx/xxxx – TBD |
0022A | ADM SARSCOV2 5X10^10VP.5ML 2 | AstraZeneca | AstraZeneca Covid-19 Vaccine Administration – Second Dose | $28.390** | xx/xx/xxxx – TBD |
91303 | SARSCOV2 VAC AD26 .5ML IM | Janssen | Janssen Covid-19 Vaccine | $0.010* | 2/27/2021 – TBD |
0031A | ADM SARSCOV2 VAC AD26 .5ML | Janssen | Janssen Covid-19 Vaccine Administration | $28.390** | 2/27/2021 – TBD |
*Since we anticipate that providers, initially, will not incur a cost for the product, CMS will update the payment allowance at a later date. Providers should not bill for the product if they received it for free.
**These rates will also be geographically adjusted for many providers. For providers and suppliers with payments that are geographically adjusted by the methodology used by the Medicare Physician Fee Schedule, files with the geographically adjusted payment rates for COVID-19 vaccine administration are included in the “Additional Resources” section below. Certain settings utilize other payment methodologies, such as payment based on reasonable costs.
Payment Allowances and Effective Dates for COVID-19 Monoclonal Antibodies and Their Administration During the Public Health Emergency:
Code | CPT Short Descriptor | Labeler Name | Vaccine/Procedure Name | Payment Allowance | Effective Dates |
---|---|---|---|---|---|
Q0239 | bamlanivimab-xxxx | Eli Lilly | Injection, bamlanivimab, 700 mg | $0.010* | 11/10/2020 – TBD |
M0239 | bamlanivimab-xxxx infusion | Eli Lilly | Intravenous infusion, bamlanivimab-xxxx, includes infusion and post administration monitoring | $309.600*** | 11/10/2020 – TBD |
Q0243 | casirivimab and imdevimab | Regeneron | Injection, casirivimab and imdevimab, 2400 mg | $0.010* | 11/21/2020 – TBD |
M0243 | casirivi and imdevi infusion | Regeneron | intravenous infusion, casirivimab and imdevimab includes infusion and post administration monitoring | $309.600*** | 11/21/2020 – TBD |
*Since we anticipate that providers, initially, will not incur a cost for the product, CMS will update the payment allowance at a later date. Providers should not bill for the product if they received it for free.
*** Medicare will pay a rate of $309.60 for many providers. These rates will also be geographically adjusted for many providers. For providers and suppliers with payments that are geographically adjusted by the methodology used by the Medicare Physician Fee Schedule, files with the geographically adjusted payment rates for monoclonal antibody administration are included in the “Additional Resources” section below. Certain settings utilize other payment methodologies, such as payment based on reasonable costs.
Billing
- For billing single claims for COVID-19 vaccines and monoclonal antibodies, follow the instructions below.
- For roster billing and centralized billing refer to the Medicare Billing for COVID-19 Vaccine Shot Administration web page.
- When COVID-19 vaccine and monoclonal antibody doses are provided by the government without charge, only bill for the vaccine administration. Don't include the vaccine codes on the claim when the vaccines are free.
- If the patient is enrolled in a MA plan, submit your COVID-19 vaccine and monoclonal antibody infusion claims to Original Fee-for-Service Medicare in 2020 and 2021.
COVID-19 Vaccines and Administration
Code | Description | Labeler name | Vaccine/procedure name | Effective date | Dosing interval |
---|---|---|---|---|---|
91300* | SARSCOV2 VAC 30MCG/0.3ML IM | Pfizer | Pfizer-Biontech Covid-19 Vaccine | 12/11/2020 | 21 days |
0001A | ADM SARSCOV2 30MCG/0.3ML 1ST | Pfizer | Pfizer-Biontech Covid-19 Vaccine Administration – First Dose | 12/11/2020 | 21 days |
0002A | ADM SARSCOV2 30MCG/0.3ML 2ND | Pfizer | Pfizer-Biontech Covid-19 Vaccine Administration – Second Dose | 12/11/2020 | 21 days |
91301* | SARSCOV2 VAC 100MCG/0.5ML IM | Moderna | Moderna Covid-19 Vaccine | 12/18/2020 | 28 days |
0011A | ADM SARSCOV2 100MCG/0.5ML1ST | Moderna | Moderna Covid-19 Vaccine Administration – First Dose | 12/18/2020 | 28 days |
0012A | ADM SARSCOV2 100MCG/0.5ML2ND | Moderna | Moderna Covid-19 Vaccine Administration – Second Dose | 12/18/2020 | 28 days |
91302* | SARSCOV2 VAC 5X10^10VP.5MLIM | AstraZeneca | AstraZeneca Covid-19 Vaccine | TBD | 28 days |
0021A | ADM SARSCOV2 5X10^10VP.5ML 1 | AstraZeneca | AstraZeneca Covid-19 Vaccine Administration – First Dose | TBD | 28 days |
0022A | ADM SARSCOV2 5X10^10VP.5ML 2 | AstraZeneca | AstraZeneca Covid-19 Vaccine Administration – Second Dose | TBD | 28 days |
91303 | SARSCOV2 VAC AD26 .5ML IM |
Janssen | Janssen Covid-19 Vaccine _ single does | 2/27/2021 | TBD |
0031A | SARSCOV2 VAC AD26 .5ML |
Janssen | Janssen Covid-19 Vaccine Administration | 2/27/2021 | TBD |
Please Note: Providers should not bill for the cost of the vaccine itself if they received it for free.
Providers can submit claims using the following claim example:
- Claim should include the proper billing of the ICD-10 in item 21:
- Report the proper date of service
- Report the proper place of service
- Use the applicable CPT or HCPCs code:
- 0001A - Used for the first dose of Pfizer
- 0002A - Used for the 2nd dose of Pfizer
- 0011A Used for the first dose of Moderna
- 0012A - Used for the 2nd dose of Moderna
- 0021A Used for the first dose of AstraZeneca
- 0022A Used for the 2nd dose of AstraZeneca
- 0031A Used for the single dose administration of Janssen
Monoclonal Antibodies and Administration
Code | Description | Labeler name | Vaccine/procedure name | Effective date | Dosing interval |
---|---|---|---|---|---|
Q0239* | bamlanivimab-xxxx | Eli Lilly | Injection, bamlanivimab, 700 mg | 11/10/2020 | 28 days |
M0239 | bamlanivimab-xxxx infusion | Eli Lilly | Intravenous infusion, bamlanivimab-xxxx, includes infusion and post administration monitoring | 11/10/2020 | 28 days |
Q0243* | casirivimab and imdevimab | Regeneron | Injection, casirivimab and imdevimab, 2400 mg | 11/21/2020 | 28 days |
M0243 | casirivi and imdevi infusion | Regeneron | Intravenous infusion, casirivimab and imdevimab includes infusion and post administration monitoring | 11/21/2020 | 28 days |
Note: Providers should not bill for the cost of the vaccine itself if they received it for free.
Providers can submit claims using the following claim example:
Claim should include the proper billing of the ICD-10 in item 21:
- Diagnosis of U071
- Report the proper date of service
- Report the proper place of service
- Use the applicable CPT or HCPCs code:
- Q0239 – Used for the injection
- M0239 – Used for the intravenous infusion and post administration monitoring
- M0243 – Used for the injection
- Q0243 – Used for the intravenous infusion and post administration monitoring
Provider Eligibility
Are you already enrolled in Medicare?
If you’re enrolled in Medicare under these institutional or noninstitutional provider types, you don’t need to take any action to administer and bill the COVID-19 shot, either through individual claims or roster bill, without enrolling as a mass immunizer.
Institutional | Non-Institutional |
---|---|
|
|
If you are not enrolled or enrolled under these institutional or non-institutional provider type that do not allow you to bill for administering vaccines, enroll as a mass immunizer.
Institutional | Non-Institutional | Durable Medical Equipment (DME) |
---|---|---|
|
|
|
If You are Not Enrolled or Action is Needed
Hotline for Temporary Enrollment
Mass Immunizer enrolling over the phone is quick and easy.
- NGS Provider Enrollment COVID-19 Toll Free Temporary Enrollment Hotline 888-802-3898
- Must qualify as a mass immunizer or other Medicare provider type that allows billing for administering vaccines and provide the following information:
- LBN
- NPI
- TIN
- Practice location and state license, if applicable.
- After established, to be a permanent enrollment, send in CMS forms at least 30 days after the lifting of the COVID-19 PHE waiver.
Important: If NGS is not your MAC, CMS has a list of each MACs enrollment hotline number, state and territory on the COVID-19 MAC Webpages and Hotlines.
Mass Immunizers Can Enroll as a Centralized Biller
- Mass immunizers can roster bill Novitas with a single enrollment regardless of the geographic location.
- You must operate in at least three MAC Jurisdictions and get prior approval from Novitas to centralize bill.
Contact Novitas: 855-247-8428
Additional Resources
-
- NGS COVID-19 web page is available via our website banner
- CMS Enrollment for Administering COVID-19 Vaccine Shots
- CMS COVID-19 provider toolkit
- CDC COVID-19 vaccination communication toolkit for medical centers, clinics, and clinicians
- FDA COVID-19 vaccines webpage
- Medicare Learning Network® –MLN Connects Special Edition Articles
Billing Frequently Asked Questions
CMS Coronavirus (COVID-19) Current Emergencies, Waivers and Flexibilities Resources
Revised 6/3/2021
Posted 1/12/2021